5H0N
Crystal structure of HIV-1 fusion inhibitor MT-WQ-IDL bound to gp41 NHR
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRF BEAMLINE BL19U1 |
Synchrotron site | SSRF |
Beamline | BL19U1 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2016-04-27 |
Detector | DECTRIS PILATUS3 2M |
Wavelength(s) | 0.97853 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 55.417, 79.236, 70.936 |
Unit cell angles | 90.00, 111.24, 90.00 |
Refinement procedure
Resolution | 39.600 - 2.800 |
R-factor | 0.2392 |
Rwork | 0.237 |
R-free | 0.27590 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 5cmz |
RMSD bond length | 0.004 |
RMSD bond angle | 0.465 |
Data reduction software | HKL-3000 |
Data scaling software | HKL-3000 |
Phasing software | PHENIX |
Refinement software | PHENIX ((1.10.1_2155: ???)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 39.600 | 2.850 |
High resolution limit [Å] | 2.800 | 2.800 |
Rmerge | 0.079 | |
Number of reflections | 12009 | |
<I/σ(I)> | 9.3 | |
Completeness [%] | 84.6 | |
Redundancy | 2.5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 289 | 0.2 M Zinc Acetate, 0.1 M Imidazole: HCl pH 8.0, 20% (v/v) 1,4-Butanediol |